CWAM
ANIK icon

Columbia Wanger Asset Management’s Anika Therapeutics ANIK Stock Holding History

Columbia Wanger Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12.8M Buy
236,571
+60,861
+35% +$3.37M 0.19% 166
2017
Q3 		$10.2M Sell
175,710
-99,914
-36% -$5.22M 0.15% 170
2017
Q2 		$13.6M Buy
275,624
+105,395
+62% +$4.85M 0.19% 165
2017
Q1 		$7.39M Buy
+170,229
New +$8.13M 0.1% 192

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Columbia Wanger Asset Management's ANIK Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Anika Therapeutics (ANIK) stake by 35% in Q4 2017, buying an estimated $3.37M and bringing the position to 236,571 shares worth $12.8M. The position accounts for 0.19% of the portfolio, ranked #166.

Columbia Wanger Asset Management first reported a position in ANIK in Q1 2017 and has held it in 4 quarters since. The position peaked at $13.6M in Q2 2017. 172 funds tracked by Wall St. Rank hold ANIK as of Q4 2017.

  • Columbia Wanger Asset Management held 236,571 shares of Anika Therapeutics worth $12.8M as of Q4 2017.
  • Columbia Wanger Asset Management bought 60,861 Anika Therapeutics shares in Q4 2017, an estimated $3.37M.
  • Anika Therapeutics made up 0.19% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #166 holding.
  • Columbia Wanger Asset Management first reported a position in Anika Therapeutics in Q1 2017 and has held it in 4 quarters since.
  • Columbia Wanger Asset Management's Anika Therapeutics position peaked at $13.6M in Q2 2017.
  • 172 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.